JEPRX | PRRCX | JEPRX / PRRCX | |
Total Expense Ratio | 0.35 | 2.14 | 16% |
Annual Report Gross Expense Ratio | 0.35 | 2.14 | 16% |
Fund Existence | 7 years | 15 years | - |
Gain YTD | -0.785 | -1.311 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 15000000 | 1000 | 1,500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.26B | 111M | 5,642% |
Annual Yield % from dividends | 8.30 | 11.76 | 71% |
Returns for 1 year | 6.01 | -0.05 | -11,892% |
Returns for 3 years | 28.37 | 11.72 | 242% |
Returns for 5 years | 73.06 | 27.75 | 263% |
Returns for 10 years | N/A | -0.12 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DBEZ | 51.35 | 0.27 | +0.54% |
Xtrackers MSCI Eurozone Hedged Eq ETF | |||
XHYE | 37.15 | 0.15 | +0.39% |
BondBloxx US High Yield Energy Sctr ETF | |||
EMBD | 22.73 | -0.01 | -0.04% |
Global X Emerging Markets Bond ETF | |||
VNQI | 43.12 | -0.54 | -1.24% |
Vanguard Global ex-US Real Est ETF | |||
PPH | 85.73 | -1.39 | -1.60% |
VanEck Pharmaceutical ETF |